CVE-2020-27266 Explained : Impact and Mitigation

SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A are affected by a client-side control vulnerability that enables physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.

Understanding CVE-2020-27266

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A, a vulnerability allows attackers to bypass user authentication checks.

What is CVE-2020-27266?

The vulnerability in the insulin pump and its mobile applications permits nearby attackers to bypass user authentication checks through Bluetooth Low Energy.

The Impact of CVE-2020-27266

Attackers in close physical proximity can exploit the vulnerability to circumvent user authentication checks, potentially compromising the security of the affected devices.

Technical Details of CVE-2020-27266

The vulnerability details and affected systems.

Vulnerability Description

A client-side control vulnerability in SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A allows attackers to bypass user authentication checks via Bluetooth Low Energy.

Affected Systems and Versions

Product: SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, AnyDana-A
Versions Affected: All versions prior to 3.0

Exploitation Mechanism

Attackers need to be physically close to the devices to exploit the vulnerability through Bluetooth Low Energy.

Mitigation and Prevention

Steps to mitigate and prevent exploitation of the vulnerability.

Immediate Steps to Take

Update affected devices to version 3.0 or newer to address the vulnerability.
Avoid connecting to unknown or untrusted Bluetooth devices.

Long-Term Security Practices

Regularly update software and firmware of medical devices to patch security vulnerabilities.
Implement strong authentication mechanisms to enhance device security.

Patching and Updates

Stay informed about security advisories and updates from the device manufacturer.